1-7 of 7
Keywords: inhibitors
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Articles
Biochem J (2020) 477 (16): 2971–2980.
Published: 21 August 2020
...). This modification can lead to transcriptional activation or repression of cancer-related genes. To date, a number of inhibitors, based on natural peptide substrates, have been developed for the PRMT family of enzymes. However, because peptides are easily degraded in vivo , the utility of these inhibitors...
Includes: Supplementary data
Articles
Articles
Biochem J (2002) 361 (1): 1–25.
Published: 17 December 2001
..., the therapeutic potential of suppressing the nucleoside phosphorylase activity in either family of enzymes has motivated efforts to design potent inhibitors. Several research groups have synthesized a variety of nucleoside phosphorylase inhibitors that are at various stages of preclinical and clinical evaluation...
Articles
Articles
Biochem J (1999) 339 (3): 705–712.
Published: 26 April 1999
... 1999 1999 angiostatin inhibitors interleukin-6 plasmin serine proteinase Biochem. J. (1999) 339, 705 712 (Printed in Great Britain) 705 Extrahepatic synthesis of plasminogen in the human cornea is up-regulated by interleukins-1a and -1b Sally S. TWINING1, Patricia M. WILSON and Chatri...
Articles
Biochem J (1999) 339 (3): 607–614.
Published: 26 April 1999
... behaviour for each isoform. Weakly binding inhibitors show variable behaviour in enzyme assays, with apparent inhibitory activity being markedly influenced by experimental conditions; determination of kinetic constants with this class is unreliable and IC 50 values are strongly dependent on assay conditions...